⁉️What on earth is Lp (a) and why does it matter⁉️ Need a primer this mysterious little molecule❓ Look no further than my first ever @CardioNerds InfoGraphic below 👇

If you’re interested in cardiology and medical education, @CardioNerds is for you! Last day to apply! ⤵️

Can’t wait to get started with this amazing crew @Deoliveiragdc @CFAndersenMD @DzekemB @RamaelOhiomoba! Missing @MatthewAlsaloum, Aileen and Mike! Thank you, Chiefs @BrighamFellows!

Applications for the next cohort of the @CardioNerds Academy are due April 28th! 🌟 Revised curriculum tailored to the evolving landscape of digital MedEd 🌟 Develop skills in scientific writing, visual graphic creation, & podcast development 🔗docs.google.com/forms/d/e/1F…

In @JAMACardio, we compare cardiovascular hospitalization rates in the US 🇺🇸 to another high-income country w/ a universal health system - Denmark 🇩🇰 CV hospitalizations were 1.5X ⬆️ US vs Denmark, driven by MI & HF. Income-based gaps also greater in 🇺🇸 jamanetwork.com/journals/jam…

1/20: 50 y/o M with HTN & a family history of premature CAD presents to discuss the results of his labs. His Lp(a) is 200 nmol/L. His 10-year ASCVD risk based on the pooled cohort equation is 9.1%. What does his elevated Lp(a) level signify? How should your management change?

Check out our latest infographic on familial hypercholesterolemia❕ Learn all about: 🔸Epidemiology & Genetics 🔸Diagnosis 🔸Management @CardioNerds

Couldn't be more thrilled to be sticking around Boston & MGB for CV fellowship!

Check out some of the work from our group at #AHA24 @AHAScience Saturday 🔸Lipoprotein a and outcomes after coronary angiography (early career award finalist) @KelvinS_MD @CFAndersenMD with @mchonig 🔸An integrated germline and somatic genomic model improves risk prediction for coronary artery disease @MinSeoKim_MD Xiong Yang with @pnatarajanmd and @wallacemwang 🔸Characterization of cardiac allograft vasculopathy on serial coronary angiography of heart transplant patients Brian Huang with @GLewisCardiol 🔸Integrating clinical, genetic, and electrocardiographic-based artificial intelligence to estimate risk of incident atrial fibrillation @ShinoKany with @shaan_khurshid and @patrick_ellinor Sunday 🔸Quantifying the burden of high polygenic risk for cardiometabolic disease in a US-based healthcare system biobank Anika Misra with @AniruddhPatelMD and @pnatarajanmd 🔸Comparative performance of PREVENT and Pooled Cohort Equations to predict cardiovascular disease in multisite healthcare populations @somijemmacho with @pnatarajanmd Monday 🔸Diagnostic yield and testing of an invasive coronary function testing program Fouad Bitar @mghcvrc @broadinstitute @MGHHeartHealth @mghmedres

Two important implications of this NHANES-based paper from @ShoaClarke @blakewthomson @StanfordMed. For younger adults (20-39yo), (1) current risk prediction is woefully insufficient, and (2) when elevated risk is recognized, there needs to be markedly better implementation of statins sciencedirect.com/science/ar…

Another outcomes trial win for GLP-1 medicines now with Semaglutide and the ESSENCE trial in metabolic liver disease with reduction in both inflammation and fibrosis #MASH novonordisk.com/content/nnco…

Super proud of this work comparing plaque burden assessment by CCTA and CAC scoring. Big thanks to an all-star team of imaging experts for their mentorship and guidance! @RAQuintMD @TiffanyDong6 @MichaelJBlaha @lesleejshaw

🚨 Now recruiting a postdoctoral research fellow to join us @ the @mghcvrc @MGHHeartHealth @broadinstitute! Interested in applying genetics 🧬 / multi-omics 🧪 at the intersection of cardiovascular 🫀, reproductive 🤰, and aging 🧓 biology? Apply here: partners.taleo.net/careersec…

Excited for @CFAndersenMD @mghmedres presenting work on Lp(a) testing in @MassGenBrigham mentored by @mchonig for @MGHMedicine Grand Rounds!

‼️Excited to release my infographic on invasive🫀pressure ratios in the cath lab👇🥳 Initially, I didn't understand the "how" 🤔or "why" 🤷‍♀️behind these tools. Now, I hope this can help others learn too! 🤓 🙏to @nazliokumus, @a_h_ghoneem, and the @CardioNerds team for the help!

In this week's edition of things-I-got-wrong-on-rounds-and-then-turned-into-something-for-cardionerds I present to you...an infographic about Angry Purkinje Syndrome 😡 @CardioNerds #DrMadiasNeedsATwitter (click to see the whole thing!)

Now in #EJPC @ESC_Journals, @CFAndersenMD @mghmedres 🔎s Lp(a) testing 🧪 across Mass General Brigham 2000-2023 66,937 Lp(a) assays 5.8% w/ coronary 🫀 dz had testing ⬇️ testing in women (OR 0.73), Black pts (0.58) Testing more common *after* CHD dx 👇 academic.oup.com/eurjpc/adva…

Spaced repetition on the go🔥 Love this idea from the superb @RichardAFerraro

I’ll start with the overview and recommendations regarding Lp(a) as a risk factor #KnowLpa @nationallipid

Incredible experience presenting at my first ACC conference. Big thanks to @mchonig for sponsoring!

@CFAndersenMD @mghmedres presenting data on trends/disparities in Lp(a) testing 🧪 in the MGB system from 2000-present at #ACC24 @ACCinTouch ▪️Testing rates low across the study period but ⬆️ing since 2020 ▪️Women and Black patients less likely to be tested Paper coming soon!